{"disease":{"id":"ethylene-glycol-toxicity","name":"Ethylene Glycol Toxicity","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"antizol","indication_name":"Ethylene Glycol Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Antizol","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Alcohol dehydrogenase, Alcohol dehydrogenase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"fomepizole","indication_name":"Ethylene Glycol Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Antizol","generic_name":"FOMEPIZOLE","company_name":"Par Pharm Inc","drug_phase":"marketed","molecular_target":"Alcohol dehydrogenase","drug_class":"Antidote [EPC]","quality_score":10,"revenue":null,"mechanism":"Antizol works by competitively inhibiting the enzyme alcohol dehydrogenase, which is responsible for converting toxic alcohols into their more toxic metabolites."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}